CITADEL ADVISORS LLC

Holdings History for Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN)

Symbol
TERN on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
3,465,307 shares
Security Ownership %
4.1%
Shares, Excluding Options vs Price
Value, Excluding Options

Kenneth Griffin ownership in Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

14 Feb 2025 - Kenneth Griffin has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,465,307 shares of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN). This represents 4.1% ownership of the company. This is the first filing by CITADEL ADVISORS LLC disclosing ownership of Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.